Packaging compatibility is often reduced to leakage, color and pump function. Those checks miss substances that can migrate from resin, elastomer, adhesive, ink or processing aids into the formula. Cosmetic projects do not need to copy pharmaceutical programs blindly, but they do need a proportionate risk assessment tied to the exact serum and market pack.
Separate extractables from leachables
Extractables are obtained under exaggerated laboratory conditions and help identify potential migrants. Leachables are substances found in product under actual or simulated storage. A long extractables list is not proof of consumer exposure, and a clean supplier summary is not proof that the finished serum has no migrants.
Map every direct and indirect contact material
List bottle, pump body, piston, dip tube, gasket, spring coating, liner, adhesive, ink and overlabel. Record resin grade, colorant, recycled-content claim and manufacturing site. External label chemistry can matter through diffusion or set-off, while metal components can affect copper peptide color even without obvious corrosion.
Use formula chemistry to rank risk
Water, glycols, ethanol, surfactants, oils, pH and fragrance determine extraction power. A neutral water gel and an ethanol-containing serum do not justify the same assumption. Copper peptide and colored formulas also require assessment of metal-contact and analytical interference. Start with worst-contact area and longest exposure.
Design stability samples for migration questions
Store the final formula in the final decorated pack, including inverted or horizontal orientation when realistic. Keep glass or suitable inert controls to distinguish package-derived change from formula aging. Trend odor, color, pH, viscosity, package function and targeted or non-targeted analytical findings where risk warrants.
Do not confuse adsorption with migration
Loss of peptide onto a surface and migration out of that surface are different mechanisms. Both can happen. If peptide recovery falls, check blank containers, rinses and mass balance before blaming degradation. If a new odor or peak appears, compare package controls and component lots.
Control supplier and resin changes
A component with the same drawing may use a new resin, colorant, antioxidant, mold release or gasket. Require change notification and lot traceability. Requalify meaningful changes with formula compatibility and safety review. A packaging certificate from a different component family is not transferable evidence.
Document a proportionate conclusion
Record hazard, likely migration, exposure, toxicological review where needed and impact on formula quality. Do not market pharmaceutical-grade packaging without a defined basis. The final decision should link exact component codes, serum batch, study conditions and destination-market safety file.
Questions buyers also ask
What is the difference between extractables and leachables?
Extractables are potential migrants under forced conditions; leachables are substances that actually migrate under product-use conditions.
Do cosmetic peptide serums need leachables testing?
The scope should be risk-based, considering formula chemistry, contact materials, exposure, market requirements and supplier data.
Can a pump pass compatibility but still affect the serum?
Yes. Dose and leakage may pass while migration, adsorption, odor or metal-contact effects remain.
Does glass eliminate packaging migration risk?
No. Closures, coatings, labels and processing residues still need consideration, and glass can create other compatibility issues.
Evidence and compliance note
Supplier data and laboratory methods inform development, but they do not replace safety, stability, microbial and performance evidence for the finished cosmetic. Specifications, claims and controls must match the exact material, process, pack and destination market.
Review the exact commercial grade
Send the product code, active basis, formula target, package, quantity and destination market for a B2B technical review.
Send a project briefPublished August 29, 2026. Technical B2B guidance; not medical or legal advice.
